financetom
Business
financetom
/
Business
/
First Bancorp Reports New CEO Appointment at First Bank
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
First Bancorp Reports New CEO Appointment at First Bank
Feb 6, 2025 2:54 PM

05:35 PM EST, 02/06/2025 (MT Newswires) -- First Bancorp (FBNC), the parent company of First Bank, reported Thursday the promotion of G. Adam Currie to the role of chief executive officer from president of the bank.

Currie will replace Michael Mayer, who will remain as president of First Bancorp until early 2026, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Distribution Solutions Group's Gexpro Services to Buy Tech-Component Resources
Distribution Solutions Group's Gexpro Services to Buy Tech-Component Resources
Sep 26, 2024
05:10 PM EDT, 09/24/2024 (MT Newswires) -- Distribution Solutions Group ( DSGR ) said Tuesday that its operating company Gexpro Services agreed to acquire Tech-Component Resources, a Southeast Asian distributor of fasteners, mechanical parts and other industrial products. The deal will be financed using current cash reserves and is slated to close in Q4, according to Distribution Solutions ( DSGR...
Progress Software Stock Jumps On Q3 Earnings: Revenue Beat, EPS Beat, Raised Guidance And More
Progress Software Stock Jumps On Q3 Earnings: Revenue Beat, EPS Beat, Raised Guidance And More
Sep 26, 2024
Progress Software Corp ( PRGS ) shares are trading higher in Tuesday’s after-hours session after the company reported better-than-expected financial results for the third quarter. Q3 Revenue: $178.69 million, versus estimates of $175.94 million Q3 EPS: $1.26, versus estimates of $1.14 Total revenue was up 2% on a year-over-year basis. Annualized recurring revenue totaled $582 million, “relatively flat” on a...
Amgen's experimental skin disease drug meets main goals in study
Amgen's experimental skin disease drug meets main goals in study
Sep 26, 2024
Sept 24 (Reuters) - Amgen ( AMGN ) said on Tuesday its experimental drug, rocatinlimab, met the main goals in a late stage study testing it as a treatment for an inflammatory skin condition known as atopic dermatitis. ...
--KB Home Says Bought Back $150 Million Shares in Fiscal Q3, Bringing 2024 Repurchases to $250 Million
--KB Home Says Bought Back $150 Million Shares in Fiscal Q3, Bringing 2024 Repurchases to $250 Million
Sep 26, 2024
04:47 PM EDT, 09/24/2024 (MT Newswires) -- Price: 81.71, Change: -5.72, Percent Change: -6.54 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved